P. Marik et al., A comparison of bronchodilator therapy delivered by nebulization and metered-dose inhaler in mechanically ventilated patients, CHEST, 115(6), 1999, pp. 1653-1657
Citations number
20
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background: The optimal method of delivering bronchodilators in mechanicall
y ventilated patients is unclear. The purpose of this study was to compare
die pulmonary bioavailability of albuterol delivered by the nebulizer, the
metered-dose inhaler (MDI) and spacer, and the light-angle MDI adaptor in v
entilated patients using urinary analysis of drug levels.
Methods: Mechanically ventilated patients who had not received a bronchodil
ator in the previous 48 h and who had normal renal function were randomized
to receive the following: (1) five puffs (450 mu g) of albuterol delivered
by the MDI with a small volume spacer; (2) five puffs of albuterol deliver
ed by the MDI port on a right-angle adaptor; or (3) 2.5 mg albuterol delive
red by a nebulizer. Urine was collected 6 h after the administration of the
drug, and the amounts of albuterol and its sulfate conjugate were determin
ed in the urine by a chromatographic assay.
Results: Thirty patients were studied, 10 in each group: their mean age and
serum creatinine level were 62 years and 1.3 mg/dL, respectively. With the
MDI and spacer, (mean +/- SD) 169 +/- 129 mu g albuterol (38%) was recover
ed in the urine; with the nebulizer, 409 +/- 515 mu g albuterol (16%) was r
ecovered in the urine; and with the MDI port on the right-angle adaptor, 41
+/- 61 mu g albuterol (9%) was recovered in the urine (p = 0.02 between gr
oups). The level of albuterol in the urine was below the level of detection
in four patients in whom the drug was delivered using the right-angle MDI
adaptor.
Conclusion: The three delivery systems varied markedly in their efficiency
of drug delivery to the lung. As previous studies have confirmed, this stud
y has demonstrated that using an MDI and spacer is an efficient method for
delivering inhaled bronchodilators to the lung. The pulmonary bioavailabili
ty was poor with the right-angle MDI port. This port should not be used to
deliver bronchodilators in mechanically ventilated patients.